Atomo Diagnostics Ltd has released a press release.
Update to Atomos US market strategy
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Atomo Diagnostics
- Quarterly Activity Report & Appendix 4C - 31 March 2021
- Viatris & Atomo to Support Unitaid HIV Self-Test Expansion
- S&P DJI Announces March 2021 Quarterly Rebalance
- Quarterly Activity Report & Appendix 4C - 31 December 2020
- Atomo provides update on its HIV Rapid Test business
Later from Atomo Diagnostics
- Access Bio receives FDA clearance for COVID-19 antibody test
- Appendix 4C - 30 June 2021
- Quarterly Activity Report - 30 June 2021
- Appendix 4E & Annual Financial Report
- FY21 Results Presentation
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics